In many cases, it's not until memory problems start creeping up that most people learn they have Alzheimer's disease. By then, the disease may already be progressing, leaving limited options for ...

The FDA recently cleared the Lumipulse blood test for early diagnosis of Alzheimer's disease in people 55 and over with memory loss. The noninvasive Lumipulse blood test measures the levels of two ...

We're now closer to being able to diagnose the most common form of dementia with a simple test. The Food and Drug Administration on May 16 said it cleared the first blood test for Alzheimer's disease.

A pioneering study indicates that Alzheimer’s disease is considerably more widespread among individuals over 85 than previously believed. The research also found that over one in ten people aged 70 ...

In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, accessible and inexpensive than other existing tests. When you purchase through ...

FILE - R. Scott Turner, Professor of Neurology and Director of the Memory Disorder Center at Georgetown University Hospital, points to PET scan results that are part of a study on Alzheimer's disease ...

Mayo Clinic researchers validated an FDA-approved blood test that diagnoses Alzheimer’s disease with 95% sensitivity and 82% specificity in outpatient settings. The test offers a less invasive and ...

The early signs of Alzheimer's disease—more frequent memory loss, increased confusion—can be difficult to detect, often delaying diagnosis. That could change with an inexpensive and noninvasive blood ...

The earlier Alzheimer’s disease can be diagnosed, the better the outcomes; however, it can be hard to diagnose the disease in its earliest stages. The United States Food and Drug Administration ...

Researchers at Johns Hopkins Medicine, led by Bindu Paul, an associate professor of pharmacology, psychiatry and neuroscience at the Johns Hopkins University School of Medicine, reported new evidence ...

The Montreal Cognitive Assessment is a 30-point exam meant to screen for Alzheimer's and other cognitive impairments in older adults.